Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Alger Institutional

Alger Small Cap Growth Institutional Fund Alger Small Cap Growth Institutional Fund Class I (ALSRX)

Ticker ALSRX · Since 1993-11-08 · · Holdings as of Jul 31, 2026

Expense ratio
1.39%$139/yr per $10k
5-yr return
−5.3%annualized
1-yr return
+4.9%as of Dec 2025
Net assets
$80.6Mall share classes
Holdings
111

Bottom line

Is ALSRX a good fund? The bottom line

ALSRX is a share class of Alger Small Cap Growth Institutional Fund, an actively managed small-cap mutual fund from Alger Institutional.

Its expense ratio is 1.39% — about $139 a year on every $10,000 invested, more expensive than 81% of small-cap funds we track.

It returned +4.9% over one year, −5.3% a year over five years, +8.4% a year over ten (as of Dec 31, 2025, per its prospectus).

With $80.6 million in net assets and 111 holdings, its largest position is Dreyfus Treasury Obligations Cash Management (6.4%) and the top 10 make up 33% of the portfolio.

What to watch

  • Expensive for its category (1.39%)
  • 5-year return in the bottom quarter of its category

Updated Nov 19, 2026

What ALSRX invests in

Alger Small Cap Growth Institutional Fund seeks long-term capital appreciation.

The Manager believes companies undergoing Positive Dynamic Change offer the best opportunities. Positive Dynamic Change refers to companies realizing High Unit Volume Growth or companies undergoing Positive Lifecycle Change. High Unit Volume Growth companies are traditional growth companies experiencing, for example, rapidly growing demand or market dominance. Positive Lifecycle Change companies are, for example, companies benefitting from new regulations, a new product innovation or new management. The Fund focuses on small, fast-growing companies that the Manager believes offer innovative products, services or technologies to a rapidly-expanding marketplace. The Fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies that, at the time of purchase of the securities, have a total market capitalization range of…

From the fund's prospectus (filed Feb 27, 2026).

ALSRX performance

Fund calendar-year total returns, 2016–2025 2016: +7.1%; 2017: +28.4%; 2018: +0.0%; 2019: +29.8%; 2020: +64.9%; 2021: −4.9%; 2022: −38.2%; 2023: +14.8%; 2024: +7.8%; 2025: +4.9% +7% 2016 +28% 2017 +0% 2018 +30% 2019 +65% 2020 −5% 2021 −38% 2022 +15% 2023 +8% 2024 +5% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
ALSRX+4.9%−5.3%+8.4%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full ALSRX performance history →

What ALSRX costs

On a $10,000 investment, ALSRX's 1.39% expense ratio costs about $139 a year. The prospectus estimates $1,669 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full ALSRX fee table →

ALSRX top 10 holdings

#Holding% of fund
1Dreyfus Treasury Obligations Cash Management6.38%
2Forte Biosciences Inc FBRX4.41%
3Chime Financial Inc CHYM4.18%
4Guardant Health Inc GH3.19%
5Gates Industrial Corporation Ltd GTES2.95%
6Victoria's Secret & Company VSCO2.70%
7Rbc Bearings Inc RBC2.58%
8Tutor Perini Corp TPC2.51%
9Adaptive Biotechnologies Corp ADPT2.28%
10Absci Corp ABSI1.80%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 33% of the fund. See all top 25 holdings and asset mix →

Alternatives to ALSRX

More funds like ALSRX →

ALSRX FAQ

What is the expense ratio of ALSRX?
ALSRX's expense ratio is 1.39%, which works out to about $139 a year for every $10,000 invested. The prospectus estimates total costs of $1,669 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is ALSRX a good investment?
It depends on your goals, but the data points to: expensive for its category (1.39%); 5-year return in the bottom quarter of its category. This is general information, not personalized advice.
What does ALSRX hold?
ALSRX's largest holdings are Dreyfus Treasury Obligations Cash Management (6.4%), Forte Biosciences Inc (4.4%), Chime Financial Inc (4.2%), Guardant Health Inc (3.2%), Gates Industrial Corporation Ltd (2.9%). It holds 111 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is ALSRX's 5-year return?
ALSRX returned −5.3% a year over the five years ending Dec 31, 2025, and +8.4% a year over ten years. Past performance does not guarantee future results.
Who manages ALSRX?
ALSRX is offered by Alger Institutional through Alger Institutional Funds.